EB – Inherited Epidermolysis Bullosa and skin fragility syndromes – Darier disease – Hailey-Hailey disease
Thematic group
Chairs and Focus
Related Conditions
Participating Reference Centres
- AOU Padua – Azienda Ospedale Università di Padova
- APHP – Hôpital Necker-Enfants malades
- ASL Tuscan Centre
- CHU de Rouen
- Colentina Clinical Hospital
- EB Haus Austria
- Fondazione Policlinico Universitario A. Gemelli – Roma
- Guy’s and St Thomas’ NHS Foundation Trust – Dept of oral Dermatology
- Helsinki University Hospital
- Hospital Na Bulovce
- Hospital of Lithuanian University of Health Sciences Kauno Klinikos
- IRCCS IDI Foundation Luigi Maria Monti – Rome
- Klinikum der Universität München
- Saint Anna University Hospital in Brno
- Spedali Civili di Brescia – Brescia
- Universitätsklinikum Erlangen
- Universitätsklinikum Freiburg – Center for Skin Fragility & Epidermolysis bullosa
- Universitätsklinikum Schleswig-Holstein
- Universitätsklinikum Würzburg
- University Hospital Centre Zagreb
- University Hospital Leuven
- University Medical Centre Groningen
Dashboard
Legend for guidelines and publications

Clinical Outcome Measures
No public document yet
Emergency Cards
- Emergency Card EB Italian version – Foundation IRCCS CA’Granda Ospedale Maggiore polyclinic, Milan
- Emergency card EB Czech version – University Hospital Brno, EB Centrum CR
- Emergency Card EB Dutch version – University Hospital Leuven
- Emergency Card EB Dutch version – University Medical Centre Groningen
- Emergency Card EB English version – Birmingham Children’s Hospital NHS Foundation Trust
- Emergency Card EB English version – Guy’s and St Thomas’ NHS Foundation Trust
- Emergency Card EB French version – University Hospital Leuven
- Emergency Card EB German version – EBHaus Austria
- Emergency Card EB German version – Universitätsklinikum Freiburg
- Emergency Card EB Italian version – AOU, Bologna
- Emergency Card EB Italian version – IRCCS IDI foundation Luigi Maria Monti, Rome
- Emergency Card EB Italian version – Pediatric hospital Bambino Gesù, Rome
Guidelines & Recommendations
Management of children with Epidermolysis Bullosa: Therapeutic education for parents and carers – in ITALIAN
Management of children with Epidermolysis Bullosa: Therapeutic education for parents and carers – in ENGLISH
Provision of Palliative and End-of-Life Care
Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa
- Preventative nutritional care guideline
Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases
Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines
- Occupational therapy for epidermolysis bullosa: clinical practice guidelines
- Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
Foot care in epidermolysis bullosa: evidence-based guideline
Skin and wound care in epidermolysis bullosa
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines
Pain care for patients with epidermolysis bullosa: best care practice guidelines
Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa
Oral Health Care for Patients with Epidermolysis Bullosa – Best Clinical Practice Guidelines
Psychosocial Guidance for social and healthcare professionals/ epidermolysis bullosa (EB) teams
Publications
COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study
Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts
STAT3 targeting in dystrophic epidermolysis bullosa
- ERN-Skin clinical research update for Epidermolysis Bullosa (October 2020)
Currently recruiting clinical therapy trials for Epidermolysis Bullosa (October 2020)
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients
Biallelic KRT5 mutations in autosomal recessive epidermolysis bullosa simplex, including a complete human keratin 5 “knock-out”
Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa
Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa part 2
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma
Features of Epidermolysis Bullosa Simplex due to KLHL24 Mutations in 3 Italian Cases
Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa
Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis
Epidermolysis Bullosa Simplex with KLHL24 Mutations Is Associated with Dilated Cardiomyopathy
Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network : Example of a centre of expertise implemented in a European reference network to face the burden of a rare disease
Training
- Epidermolysis bullosa and breastfeeding
- Epidermolysis bullosa and oral hygiene
- Hand mobility exercises for children suffering from epidermolysis bullosa
- Training on specific hand care for patients with epidermolysis bullosa
- Cardiomyopathy in recessive dystrophic epidermolysis bullosa (RDEB)
- Dental care pathways for patients with epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases
- Inflammatory mediators in EB
- Inflammatory mediators in EB
- Practical management of epidermolysis bullosa in the newborn: consensus statement from the European Reference Network for Rare Skin Diseases